BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27385098)

  • 1. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.
    Pinet S; Bessette B; Vedrenne N; Lacroix A; Richard L; Jauberteau MO; Battu S; Lalloué F
    Oncotarget; 2016 Aug; 7(31):50349-50364. PubMed ID: 27385098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p75 neurotrophin receptor and pro-BDNF promote cell survival and migration in clear cell renal cell carcinoma.
    De la Cruz-Morcillo MA; Berger J; Sánchez-Prieto R; Saada S; Naves T; Guillaudeau A; Perraud A; Sindou P; Lacroix A; Descazeaud A; Lalloué F; Jauberteau MO
    Oncotarget; 2016 Jun; 7(23):34480-97. PubMed ID: 27120782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors.
    Wilson CM; Naves T; Vincent F; Melloni B; Bonnaud F; Lalloué F; Jauberteau MO
    J Cell Sci; 2014 Sep; 127(Pt 18):3983-97. PubMed ID: 25037567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin.
    Teng HK; Teng KK; Lee R; Wright S; Tevar S; Almeida RD; Kermani P; Torkin R; Chen ZY; Lee FS; Kraemer RT; Nykjaer A; Hempstead BL
    J Neurosci; 2005 Jun; 25(22):5455-63. PubMed ID: 15930396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
    Pinheiro KV; Thomaz A; Souza BK; Metcalfe VA; Freire NH; Brunetto AT; de Farias CB; Jaeger M; Bambini V; Smith CGS; Shaw L; Roesler R
    Mol Biol Rep; 2020 Sep; 47(9):6817-6828. PubMed ID: 32862352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
    Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
    Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer.
    Li W; Lu Y; Yu X; Yong M; Ma D; Gao Q
    J Cell Biochem; 2019 Apr; 120(4):6361-6369. PubMed ID: 30304550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas.
    Dubanet L; Bentayeb H; Petit B; Olivrie A; Saada S; de la Cruz-Morcillo MA; Lalloué F; Gourin MP; Bordessoule D; Faumont N; Delage-Corre M; Fauchais AL; Jauberteau MO; Troutaud D
    Br J Cancer; 2015 Sep; 113(6):934-44. PubMed ID: 26284337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X4R silence suppresses glioma cell growth through BDNF/TrkB/ATF4 signaling pathway.
    Huo JF; Chen XB
    J Cell Biochem; 2019 Apr; 120(4):6322-6329. PubMed ID: 30362154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WDR81 Gene Silencing Can Reduce Exosome Levels in Human U87-MG Glioblastoma Cells.
    Tadayoni Nia A; Bazi Z; Khosravi A; Oladnabi M
    J Mol Neurosci; 2021 Aug; 71(8):1696-1702. PubMed ID: 33954857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could lung cancer exosomes induce apoptosis of natural killer cells through the p75NTR-proNGF-sortilin axis?
    Zhu MC; Xiong P; Li GL; Zhu M
    Med Hypotheses; 2017 Oct; 108():151-153. PubMed ID: 29055389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
    Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
    Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.
    Cheray M; Bessette B; Lacroix A; Mélin C; Jawhari S; Pinet S; Deluche E; Clavère P; Durand K; Sanchez-Prieto R; Jauberteau MO; Battu S; Lalloué F
    J Cell Mol Med; 2017 Feb; 21(2):244-253. PubMed ID: 27641066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
    Areshkov PA; Kavsan VM
    Tsitol Genet; 2010; 44(1):3-9. PubMed ID: 20201406
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Monteforte A; Lam B; Sherman MB; Henderson K; Sligar AD; Spencer A; Tang B; Dunn AK; Baker AB
    Tissue Eng Part A; 2017 Nov; 23(21-22):1251-1261. PubMed ID: 28699397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis.
    Qin G; Li X; Chen Z; Liao G; Su Y; Chen Y; Zhang W
    Mol Neurobiol; 2017 Jul; 54(5):3264-3270. PubMed ID: 27090900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
    Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
    Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol represses YKL-40 expression in human glioma U87 cells.
    Zhang W; Murao K; Zhang X; Matsumoto K; Diah S; Okada M; Miyake K; Kawai N; Fei Z; Tamiya T
    BMC Cancer; 2010 Oct; 10():593. PubMed ID: 21029458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma.
    Shao R; Francescone R; Ngernyuang N; Bentley B; Taylor SL; Moral L; Yan W
    Carcinogenesis; 2014 Feb; 35(2):373-82. PubMed ID: 24282289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.